Other Information
−Removed: During the three months ended June 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, other than on May 1, 2023 , Medpace Investors, LLC (“MPI”) adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 500,000 shares of the Company’s common stock until September 14, 2024.
−Removed: Troendle , Chief Executive Officer and Chairman of the Board of the Company , is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI.
+Added: During the three months ended September 30, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:
+Added: Action Date Trading Arrangement Total Shares to be Purchased or Sold Duration/Expiration Date
+Added: Rule 10b5-1* Non-Rule 10b5-1**
+Added: Ewald , General Counsel and Corporate Secretary
+Added: Adopt Post-market close on
+Added: July 26, 2023 [1]
+Added: X Up to 21,850 shares to be sold
+Added: The earlier of until cancelled or 180 days from the placement of the limit order
+Added: Brady , Chief Financial Officer and Treasurer
+Added: Adopt July 31, 2023 [2]
+Added: X Up to 7,000 shares to be sold
+Added: The earlier of until cancelled or 180 days from the placement of the limit order
+Added: Medpace Investors, LLC [3] Terminate [4] September 21, 2023 X Up to 500,000 shares to be sold
+Added: September 14, 2024
+Added: * Intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: ** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: [1] Post-market close on July 26, 2023, Mr.
+Added: Ewald placed a limit order to sell up to 21,850 shares issued to him pursuant to his contemporaneous exercise of stock options.
+Added: [2] On July 31, 2023, Mr.
+Added: Brady placed a limit order to sell up to 7,000 shares issued to him pursuant to his contemporaneous exercise of stock options.
+Added: [3] August J.
+Added: Troendle , Chief Executive Officer and Chairman of the Board of the Company , is the sole manager and controlling unit holder of Medpace Investors, LLC (“MPI”) and has sole voting and investment control with respect to the securities held by MPI.
Troendle may be deemed to indirectly beneficially own the securities of the Company held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
+Added: [4] Trading arrangement was originally adopted on May 1, 2023 .
The exhibits in the accompanying Exhibit Index preceding the signature page are filed or furnished as a part of this report and are incorporated herein by reference.
20 unchanged sentences
(Principal Financial Officer)
−Removed: July 25, 2023
+Added: October 24, 2023
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.